Drug
Ilaprazole clinical trials
Also written NOLTEC.
Includes 1 study of Ilaprazole sodium.
- studies test it
- 25
- open now
- 1
- in phase 3
- 9
- first study started
- 2004
Keep track of what changes. Save the ilaprazole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Combined with it in one product
Studies by the year they started
25 studies that test it; most in 2014 (5)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 5
- Phase 3
- 9
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 23 · Other 2
Il-Yang Pharm. Co., Ltd. (13) · Livzon Pharmaceutical Group Inc. (9) · Yonsei University (1) · Inje University (1) · Takeda (1)
Often tested with
Tested in the same studies.
Aceclofenac (2) · Amoxicillin (2) · Naproxen (1) · Celecoxib (1) · Esomeprazole (1)
Studies
Open first, then newest update. How each study uses ilaprazole is read from its arms, and is right about nine times in ten.
Testing it · 25
- Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic UlcerRecruitingPhase 3Il-Yang Pharm. Co., Ltd.NCT06284876Written as Ilaprazole
- Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SRCompletedPhase 1Il-Yang Pharm. Co., Ltd.NCT06725992Written as IY-NT-SR
- Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-TCompletedPhase 1Il-Yang Pharm. Co., Ltd.NCT05509543Written as IY-NT-R
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and AceclofenacCompletedPhase 1Il-Yang Pharm. Co., Ltd.NCT05558150Written as Ilaprazole
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and IlaprazoleCompletedPhase 1Il-Yang Pharm. Co., Ltd.NCT05237297Written as Ilaprazole
- A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer BleedingCompletedPhase 3Livzon Pharmaceutical Group Inc.NCT05841394Written as Ilaprazole Sodium
- Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-TStatus unknownPhase 1Il-Yang Pharm. Co., Ltd.NCT05617651Written as IY-NT-R
- Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERDCompletedPhase 3Il-Yang Pharm. Co., Ltd.NCT03444883Written as Ilaprazole
- Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.CompletedPhase 4Il-Yang Pharm. Co., Ltd.NCT02638584Written as Ilaprazole
- The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory BiomarkerCompletedPhase 4Yonsei UniversityNCT02666976Written as Ilaprazole
- Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese PatientsCompletedPhase 3Livzon Pharmaceutical Group Inc.NCT03362281Written as Ilaprazole
- IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese PatientsCompletedPhase 2Livzon Pharmaceutical Group Inc.NCT03362268Written as Ilaprazole
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and IlaprazoleCompletedPhase 1Il-Yang Pharm. Co., Ltd.NCT02998437Written as Ilaprazole 10mg
- Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter PyloriCompletedPhase 4Livzon Pharmaceutical Group Inc.NCT02873065Written as Ilaprazole
- Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese PatientsCompletedPhase 3Livzon Pharmaceutical Group Inc.NCT02860624Written as 10 mg ilaprazole
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese PatientsCompletedPhase 2/3Livzon Pharmaceutical Group Inc.NCT02847455Written as 5 mg ilaprazole
- Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori InfectionCompletedPhase 4Il-Yang Pharm. Co., Ltd.NCT02401477Written as Ilaprazole + Amoxicillin
- Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days TreatmentCompletedPhase 3Il-Yang Pharm. Co., Ltd.NCT02084420Written as Ilaprazole
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics and SafetyCompletedPhase 1Il-Yang Pharm. Co., Ltd.NCT01820143Written as Ilaprazole
- Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic PolymorphismCompletedPhase 1Inje UniversityNCT01688544Written as Ilaprazole
See all 25 studies that test ilaprazole →
Given in every arm · 2 — ilaprazole is usual care beside what is tested
- The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori PatientsCompletedPhase 4Kyungpook National University HospitalNCT02648659Written as Ilaprazole
- Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori TreatmentStatus unknownPhase 4Yanqing LiNCT03139253Written as Ilaprazole
Codes
What other systems call ilaprazole · ClinicalTrials.gg INT004161
- MeSH (NLM) C119615ilaprazoleOne source NLM
- UNII (FDA) 776Q6XX45JILAPRAZOLEConfirmed FDA, NLM, Wikidata
- Wikidata Q15051261ilaprazoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65887IlaprazoleOne source FDA
- DrugBank DB11964One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C119615 | ilaprazole | One source NLM |
| UNII (FDA) | 776Q6XX45J | ILAPRAZOLE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q15051261 | ilaprazole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65887 | Ilaprazole | One source FDA |
| DrugBank | DB11964 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.